PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $10,109,343 | 41.23% |
OUP Management Co., LLC | 989,232 | $6,192,592 | 10.56% |
Euclidean Capital LLC | 2,545,242 | $15,933,215 | 4.09% |
Nextech Invest Ltd. | 471,284 | $2,950,238 | 1.00% |
Mesirow Financial Investment Management, Inc. | 34,748 | $217,522 | 0.92% |
Boxer Capital, LLC | 3,163,795 | $19,805 | 0.92% |
Orbimed Advisors | 6,563,077 | $41,084,862 | 0.74% |
Ghost Tree Capital, LLC | 280,981 | $1,758,941 | 0.58% |
PERSONAL CFO SOLUTIONS, LLC | 350,342 | $2,193,141 | 0.44% |
Octagon Capital Advisors LP | 470,000 | $2,942,200 | 0.41% |
Tri Locum Partners LP | 158,413 | $991,665 | 0.37% |
RTW INVESTMENTS, LP | 3,029,551 | $18,964,989 | 0.36% |
SECTORAL ASSET MANAGEMENT INC | 332,250 | $2,079,885 | 0.35% |
Avoro Capital Advisors LLC | 3,060,000 | $19,155,600 | 0.26% |
Verition Fund Management LLC | 2,364,196 | $14,799,867 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 187,800 | $1,175,628 | 0.18% |
GSA CAPITAL PARTNERS LLP | 114,604 | $717 | 0.07% |
DENALI ADVISORS LLC | 30,500 | $190,930 | 0.07% |
Virtus ETF Advisers LLC | 18,184 | $113,832 | 0.07% |
PFM Health Sciences, LP | 228,410 | $1,429,847 | 0.06% |
External links
This page lists PMV PHARMACEUTICALS INC's shareholders in Q2 2023. To view PMV PHARMACEUTICALS INC's shareholder history, click here.